Defence Therapeutics Inc.
DTCFF
$0.6447
-$0.3517-35.30%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -65.88% | -90.27% | -98.04% | -82.13% | 121.50% |
| Total Receivables | -42.31% | -45.41% | -37.61% | -31.55% | 1.84% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -85.41% | -61.08% | -88.00% | -28.22% | -6.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -66.56% | -86.79% | -93.97% | -79.10% | 54.28% |
|
|
|||||
| Total Current Assets | -66.56% | -86.79% | -93.97% | -79.10% | 54.28% |
| Net Property, Plant & Equipment | 92.72% | 327.99% | 330.87% | 437.38% | 87.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -10.03% | -0.69% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -44.70% | -73.22% | -86.91% | -69.27% | 53.53% |
|
|
|||||
| Total Accounts Payable | 43.92% | 479.05% | 954.97% | 1,067.45% | 77.83% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -21.96% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1,709.60% | 3,702.97% | 657.14% | 37.68% | -- |
| Total Other Current Liabilities | 1,709.60% | 3,702.97% | 657.14% | 37.68% | -- |
| Total Current Liabilities | 20.34% | 1,062.65% | 1,679.04% | 1,752.01% | 264.97% |
|
|
|||||
| Total Current Liabilities | 20.34% | 1,062.65% | 1,679.04% | 1,752.01% | 264.97% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 19.43% | 124.28% | 99.85% | 79.48% | 19.20% |
|
|
|||||
| Common Stock & APIC | 3.82% | 12.34% | 9.83% | 27.58% | 71.38% |
| Retained Earnings | 5.55% | -59.25% | -70.58% | -86.27% | -97.28% |
| Treasury Stock & Other | -43.37% | 365.27% | 343.76% | 337.09% | 431.16% |
| Total Common Equity | -38.10% | -834.56% | -321.43% | -272.46% | -11.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.10% | -834.56% | -321.43% | -272.46% | -11.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.10% | -834.56% | -321.43% | -272.46% | -11.93% |
|
|
|||||